Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index

Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index

Objective To investigate the impact of baseline and time‐varying factors on the risk of serious adverse events (SAEs) in patients during long‐term certolizumab pegol (CZP) treatment. Methods Safety data were pooled across 34 CZP clinical trials in rheumatoid arthritis (RA), axial spondyloarthritis (...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Vivian P. Bykerk, Andrew Blauvelt, Jeffrey R. Curtis, Cécile Gaujoux‐Viala, Tore K. Kvien, Kevin Winthrop, Nicola Tilt, Christina Popova, Xavier Mariette, Boulos Haraoui
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Wiley 2021-08-01
Saila:	ACR Open Rheumatology
Sarrera elektronikoa:	https://doi.org/10.1002/acr2.11259

Antzeko izenburuak

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
nork: Tore K Kvien, et al.
Argitaratua: (2019-05-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
nork: Vivian P. Bykerk, et al.
Argitaratua: (2023-02-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
nork: Jeffrey R. Curtis, et al.
Argitaratua: (2017-12-01)

Certolizumab pegol in the treatment of spondyloarthritis
nork: Mariusz Korkosz
Argitaratua: (2014-09-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
nork: Sh. F. Erdes
Argitaratua: (2016-02-01)

Certolizumab pegol in therapy for rheumatoid arthritis
nork: Galina Viktorovna Lukina, et al.
Argitaratua: (2012-06-01)

Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells
nork: Marie de Bourayne, et al.
Argitaratua: (2022-02-01)

Quantitation of certolizumab pegol by validated liquid chromatography methods
nork: Clóvis Dervil Appratto Cardoso Júnior, et al.
Argitaratua: (2023-11-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
nork: T. V. Korotaeva, et al.
Argitaratua: (2015-10-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
nork: Mehmet Baysal, et al.
Argitaratua: (2018-09-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
nork: M Connock, et al.
Argitaratua: (2010-10-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
nork: Lindsey J. Wanberg, et al.
Argitaratua: (2024-06-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
nork: Smolen, JS, et al.
Argitaratua: (2024)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
nork: Stéphane Paul, et al.
Argitaratua: (2020-07-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
nork: Ruiz Garcia, V, et al.
Argitaratua: (2011)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
nork: Ruiz Garcia, V, et al.
Argitaratua: (2014)

Experience with long-term use of certolizumab pegol (Cimzia)
nork: Karine Arnoldovna Lytkina, et al.
Argitaratua: (2013-10-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
nork: I.L. Khalif, et al.
Argitaratua: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
nork: Ranatunga S, et al.
Argitaratua: (2014-02-01)

Experience with long-term use of certolizumab pegol (Cimzia)
nork: Karine Arnoldovna Lytkina, et al.
Argitaratua: (2013-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
nork: Maria Majdan, et al.
Argitaratua: (2014-07-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
nork: Piotr Wiland, et al.
Argitaratua: (2011-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
nork: P. I. Novikov, et al.
Argitaratua: (2018-07-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
nork: Vera Nikolayevna Amirdjanova, et al.
Argitaratua: (2012-10-01)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
nork: A. Spadaro, et al.
Argitaratua: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
nork: Wojciech Blonski, et al.
Argitaratua: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
nork: O V Knyazev, et al.
Argitaratua: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
nork: Yael Sharon, et al.
Argitaratua: (2020-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
nork: Tanaka, Y, et al.
Argitaratua: (2023)

Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report
nork: Paolo Gisondi, et al.
Argitaratua: (2025-01-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
nork: Evgeniy L'vovich Nasonov, et al.
Argitaratua: (2011-02-01)

Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient
nork: Nouf Almuhanna, MD, et al.
Argitaratua: (2023-09-01)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
nork: A. A. Kubanov, et al.
Argitaratua: (2019-12-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
nork: Henry Alistair I, et al.
Argitaratua: (2011-11-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
nork: R. Talotta, et al.
Argitaratua: (2016-09-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
nork: Emna Hannech, et al.
Argitaratua: (2021-06-01)

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
nork: Louis Bessette, et al.
Argitaratua: (2019-03-01)

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
nork: Pablo Coto-Segura, et al.
Argitaratua: (2023-09-01)

Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases
nork: Denis Menshykau, et al.
Argitaratua: (2024-11-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
nork: Dmitry Evgenyevich Karateev, et al.
Argitaratua: (2012-04-01)